[
1. Zhijun Tan, Ying Liang, Siming Liu, Wenjun Cao, Haibo Tu, Lingxia Guo, and Yongyong Xu. Health-Related Quality of Life as Measured with EQ-5D among Populations wit hand without Specific Chronic Conditions: A Population-Based Survey in Shaanxi Province, ChinaPLoS One. 2013;8(7):e65958. Published online 2013 Jul 2. doi: 10.1371/journal.pone.0065958 PMCID: PMC3699581.10.1371/journal.pone.0065958369958123843948
]Search in Google Scholar
[
2. Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, Egmar AC, Greiner W, Gusi N, Herdman M, Jelsma J, Kind P, Scalone L, Ravens-Sieberer U. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res. 2010;19(6):875-86. doi: 10.1007/s11136-010-9648-y. PMID: 20405245; PMCID: PMC2892611.10.1007/s11136-010-9648-y289261120405245
]Search in Google Scholar
[
3. EuroQol Research Foundation. EQ-5D-Y User Guide, Version 2.0, 2020. Available from: https://euroqol.org/publications/user-guides/. Accessed on 12.05.2021.
]Search in Google Scholar
[
4. https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/valuation-standard-value-sets/ Accessed on 07.06.2021.
]Search in Google Scholar
[
5. Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717-27. doi: 10.1007/s11136-012-0322-4. PMID: 23184421; PMCID: PMC3764313.10.1007/s11136-012-0322-4376431323184421
]Search in Google Scholar
[
6. van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708-15. doi: 10.1016/j.jval.2012.02.008. PMID: 22867780.10.1016/j.jval.2012.02.00822867780
]Search in Google Scholar
[
7. Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8:13. doi:10.1186/1477-7525-8-13. PMID: 20109189; PMCID: PMC2824714.10.1186/1477-7525-8-13282471420109189
]Search in Google Scholar
[
8. Batóg P, Rencz F, Péntek M, Gulácsi L, Filipiak KJ, Prevolnik Rupel V, Simon J, Brodszky V, Baji P, Závada J, Petrova G, Rotar A, Golicki D. EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature. Kardiol Pol. 2018;76(5):860-870. doi: 10.5603/KP.a2018.0033. PMID: 29350378.10.5603/KP.a2018.003329350378
]Search in Google Scholar
[
9. Golicki D, Dudzińska M, Zwolak A, Tarach JS. Quality of life in patients with type 2 diabetes in Poland - comparison with the general population using the EQ-5D questionnaire, Adv Clin Exp Med, doi: 10.17219/acem/38137.10.17219/acem/3813725923098
]Search in Google Scholar
[
10. Bulamu NB, Kaambwa B, Ratcliffe J. A systematic review of instruments for measuring outcomes in economic evaluation within aged care. Health Qual Life Outcomes. 2015 Nov;13:179. DOI: 10.1186/s12955-015-0372-8. PMID: 26553129; PMCID: PMC4640110.10.1186/s12955-015-0372-8464011026553129
]Search in Google Scholar
[
11. Yang Y, Brazier J, Longworth L. EQ-5D in skin conditions: an assessment of validity and responsiveness. Eur J Health Econ. 2015;16(9):927-939. doi:10.1007/s10198-014-0638-9. PMID: 25358263; PMCID: PMC4646948.10.1007/s10198-014-0638-9464694825358263
]Search in Google Scholar
[
12. Schwenkglenks M, Matter-Walstra K. Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments. Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):207-219. doi:10.1586/14737167.2016.1146594. PMID: 26808097.10.1586/14737167.2016.114659426808097
]Search in Google Scholar
[
13. Shim J, Hamilton DF. Comparative responsiveness of the PROMIS-10 Global Health and EQ-5D questionnaires in patients undergoing total knee arthroplasty. Bone Joint J. 2019;101-B(7):832-837. doi:10.1302/0301-620X.101B7.BJJ-2018-1543.R1. PMID: 31256677; PMCID: PMC6616061.10.1302/0301-620X.101B7.BJJ-2018-1543.R1661606131256677
]Search in Google Scholar
[
14. Szende A, Janssen B, Cabases J, editors. Self-Reported Population Health: An International Perspective based on EQ-5D. Dordrecht (NL): Springer; 2014. DOI: 10.1007/978-94-007-7596-1. PMID: 29787044.10.1007/978-94-007-7596-129787044
]Search in Google Scholar
[
15. Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S, Saito S, Shimozuma K. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25(3):707-19. doi: 10.1007/s11136-015-1108-2. PMID: 26303761; PMCID: PMC4759213.10.1007/s11136-015-1108-2475921326303761
]Search in Google Scholar
[
16. Janssen MF, Lubetkin EI, Sekhobo JP, Pickard AS: The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabet Med. 2011;28:395-413.10.1111/j.1464-5491.2010.03136.x21392061
]Search in Google Scholar
[
17. eq5d: Methods for Analysing EQ-5D Data and Calculating EQ-5D Index Scores https://rdrr.io/cran/eq5d/
]Search in Google Scholar
[
18. Hayes AJ, Clarke PM, Glasziou PG, Simes RJ, Drury PL, Keech AC: Can self-rated health scores be used for risk prediction in patients with type 2 diabetes? Diabetes Care. 2008;31:795-797.10.2337/dc07-139118184900
]Search in Google Scholar
[
19. Bagust A, Beale S. Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data.Health Econ. 2005;14:217-230.10.1002/hec.91015386666
]Search in Google Scholar
[
20. Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D(UKPDS 62). Med Decis Making. 2002;22:340-349.10.1177/027298902400448902
]Search in Google Scholar
[
21. Holmes J, McGill S, Kind P, Bottomley J, Gillam S, Murphy M. Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health. 2000;3:47-51.10.1046/j.1524-4733.2000.36028.x16464209
]Search in Google Scholar
[
22. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW: Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25:458-463.10.2337/diacare.25.3.45811874930
]Search in Google Scholar
[
23. Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health and Quality of Life Outcomes. 2010;8:18.10.1186/1477-7525-8-18282953120132542
]Search in Google Scholar
[
24. Holmes J, McGill S, Kind P, Bottomley J, Gillam S, et al. Health-related Quality of Life in Type 2 Diabetes (T2ARDIS-2). Value in Health 3. 2000;S47–S51.10.1046/j.1524-4733.2000.36028.x16464209
]Search in Google Scholar
[
25. Lee WJ, Song KH, Noh JH, Choi YJ, Jo MW. (2012) Health-Related Quality of Life Using the EuroQol 5D Questionnaire in Korean Patients with Type 2 Diabetes. Journal of Korean Medical Science. 2012;27:255-260.10.3346/jkms.2012.27.3.255328677122379335
]Search in Google Scholar
[
26. Redekop WK, Rutten G, Koopmanschap MA, Wolffenbuttel BHR, Stolk RP, et al. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25:458-463.10.2337/diacare.25.3.45811874930
]Search in Google Scholar
[
27. Peyrot M, Rubin RR. Persistence of depressive symptoms in diabetic adults. Diabetes Care. 1999;22:448-452.10.2337/diacare.22.3.44810097927
]Search in Google Scholar